Previous close | 121.52 |
Open | 121.55 |
Bid | 121.44 x 1100 |
Ask | 121.47 x 900 |
Day's range | 121.01 - 122.42 |
52-week range | 102.00 - 149.25 |
Volume | |
Avg. volume | 1,390,303 |
Market cap | 24.896B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 24.78 |
EPS (TTM) | 4.89 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 0.96 (0.79%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | 137.17 |
SYK and ZBH are expected to have witnessed strong procedural volume growth across the global market in the first quarter.
Within the Hips business, Zimmer Biomet (ZBH) is expected to have witnessed procedure volume recovery, banking on strategic product launches in the first quarter.
The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.